- Mercia Technologies has completed a £500,000 investment into Oxford Genetics, a synthetic biology company with significant expertise in DNA design.

This investment follows the £1.0m of additional capital which was provided by Mercia in October 2016 in order to expand the company's management team, board, patent portfolio and commercialisation strategy.

At 8:58am: [LON:MERC] Mercia Technologies Plc share price was 0p at 34.5p

Story provided by